Steven H Stein Incyte Corp (INCY) insider trading activity

Steven H Stein is EVP & Chief Medical Officer of INCYTE CORP. Currently has a direct ownership of 102,886 shares of INCY, which is worth approximately $8.4 Million. The most recent transaction as insider was on Jul 21, 2025, when has been sold 3,706 shares (Common Stock) at a price of $67.94 per share, resulting in proceeds of $251,785. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 103K

17.78% 3M change

14.3% 12M change

Total Value Held $8.4 Million

Steven H Stein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 21 2025	SELL Open market or private sale	$251,785 $67.94 p/Share	3,706 Reduced 3.48%	102,886 Common Stock
Jul 15 2025	SELL Payment of exercise price or tax liability	$108,927 $68.25 p/Share	1,596 Reduced 1.66%	94,315 Common Stock
Jul 15 2025	BUY Grant, award, or other acquisition	-	12,277 Added 10.33%	106,592 Common Stock
Jul 14 2025	SELL Open market or private sale	$1,023,763 $68.47 p/Share	14,952 Reduced 13.3%	97,466 Common Stock
Jul 14 2025	SELL Payment of exercise price or tax liability	$108,818 $69.98 p/Share	1,555 Reduced 1.6%	95,911 Common Stock
Jul 02 2025	SELL Payment of exercise price or tax liability	$866,713 $68.17 p/Share	12,714 Reduced 10.16%	112,418 Common Stock
Apr 01 2025	BUY Grant, award, or other acquisition	-	58,165 Added 31.73%	125,132 Common Stock
Jan 21 2025	SELL Open market or private sale	$897,866 $72.69 p/Share	12,352 Reduced 15.57%	66,967 Common Stock
Jan 15 2025	SELL Payment of exercise price or tax liability	$774,742 $72.46 p/Share	10,692 Reduced 11.88%	79,319 Common Stock
Aug 12 2024	SELL Open market or private sale	$703,793 $60.63 p/Share	11,608 Reduced 11.42%	90,011 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$99,908 $64.25 p/Share	1,555 Reduced 1.51%	101,619 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	-	13,895 Added 11.87%	103,174 Common Stock
Jul 02 2024	SELL Payment of exercise price or tax liability	$490,810 $59.02 p/Share	8,316 Reduced 8.52%	89,279 Common Stock
Feb 14 2024	BUY Grant, award, or other acquisition	-	7,377 Added 7.03%	97,595 Common Stock
Jan 03 2024	SELL Open market or private sale	$482,481 $65.51 p/Share	7,365 Reduced 7.55%	90,218 Common Stock
Aug 01 2023	SELL Open market or private sale	$1,361,216 $63.28 p/Share	21,511 Reduced 18.06%	97,583 Common Stock
Jul 14 2023	BUY Grant, award, or other acquisition	-	13,535 Added 10.21%	119,094 Common Stock
Jul 03 2023	SELL Payment of exercise price or tax liability	$524,079 $62.08 p/Share	8,442 Reduced 7.41%	105,559 Common Stock
Jan 20 2023	BUY Grant, award, or other acquisition	-	4,980 Added 4.19%	114,001 Common Stock
Jan 04 2023	SELL Open market or private sale	$2,265,672 $79.78 p/Share	28,399 Reduced 20.67%	109,021 Common Stock
Jul 05 2022	SELL Payment of exercise price or tax liability	$305,588 $79.25 p/Share	3,856 Reduced 2.73%	137,420 Common Stock
Jul 02 2022	BUY Grant, award, or other acquisition	-	18,941 Added 11.82%	141,276 Common Stock
Jun 28 2022	SELL Payment of exercise price or tax liability	$868,837 $75.63 p/Share	11,488 Reduced 8.58%	122,335 Common Stock
Jan 01 2022	BUY Grant, award, or other acquisition	-	28,926 Added 17.77%	133,823 Common Stock
Nov 19 2021	BUY Grant, award, or other acquisition	-	2,734 Added 2.54%	104,897 Common Stock

Also insider at

KURA

Kura Oncology, Inc. Healthcare

Director

THRX

Theseus Pharmaceuticals, Inc. Healthcare

Director

RPTX

Repare Therapeutics Inc. Healthcare

SHS

Steven H Stein

EVP & Chief Medical Officer

Wilmington, DE

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INCY shares.

Notify only if

Value

Insider Trading

Get notified when an Incyte Corp insider buys or sells INCY shares.

Notify only if

Operation

Value

Type

News

Receive news related to INCYTE CORP

Track Activities on INCY

Account